ArticleFrontiers in cardiovascular medicine2025

Valvular dysfunction and cardiovascular risk in individuals with opioid use disorder who are maintained on buprenorphine/naloxone: a focus on pan-immune-inflammation value and uric acid-to-albumin ratio.

Hatice Eyiol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.